Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C138997> ?p ?o ?g. }
Showing items 1 to 30 of
30
with 100 items per page.
- NCIT_C138997 IAO_0000115 "A receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities. Upon administration, anlotininib targets multiple RTKs, including vascular endothelial growth factor receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent may both inhibit angiogenesis and halt tumor cell growth." @default.
- NCIT_C138997 NCIT_A5 NCIT_C106428 @default.
- NCIT_C138997 NCIT_NHC0 "C138997" @default.
- NCIT_C138997 NCIT_P106 "Pharmacologic Substance" @default.
- NCIT_C138997 NCIT_P108 "Anlotinib" @default.
- NCIT_C138997 NCIT_P208 "CL526447" @default.
- NCIT_C138997 NCIT_P210 "1058156-90-3" @default.
- NCIT_C138997 NCIT_P319 "GKF8S4C432" @default.
- NCIT_C138997 NCIT_P322 "FDA" @default.
- NCIT_C138997 normalizedInformationContent "100" @default.
- NCIT_C138997 referenceCount "1" @default.
- NCIT_C138997 hasExactSynonym "AL 3818" @default.
- NCIT_C138997 hasExactSynonym "AL-3818" @default.
- NCIT_C138997 hasExactSynonym "AL3818" @default.
- NCIT_C138997 hasExactSynonym "Anlotinib" @default.
- NCIT_C138997 hasExactSynonym "CATEQUENTINIB" @default.
- NCIT_C138997 hasExactSynonym "Cyclopropanamine, 1-(((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-quinolinyl)oxy)methyl)-" @default.
- NCIT_C138997 inSubset NCIT_C63923 @default.
- NCIT_C138997 type Class @default.
- NCIT_C138997 isDefinedBy ncit.owl @default.
- NCIT_C138997 label "Anlotinib" @default.
- NCIT_C138997 subClassOf NCIT_C129824 @default.
- NCIT_C138997 subClassOf NCIT_C129825 @default.
- NCIT_C138997 subClassOf NCIT_C138997 @default.
- NCIT_C138997 subClassOf NCIT_C1742 @default.
- NCIT_C138997 subClassOf NCIT_C1908 @default.
- NCIT_C138997 subClassOf NCIT_C1909 @default.
- NCIT_C138997 subClassOf NCIT_C2189 @default.
- NCIT_C138997 subClassOf NCIT_C274 @default.
- NCIT_C138997 subClassOf NCIT_C471 @default.